PAIGE PATEL: Open Payments
NPI 1548895469 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304 in 15 payments from 8 companies in 2025. Trend: 2023 $57 · 2024 $306 · 2025 $304
Food & beverage: $304
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $100 |
| ABBVIE INC. | 2 | $51 |
| Exact Sciences Corporation | 2 | $42 |
| GlaxoSmithKline, LLC. | 1 | $32 |
| Amgen Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $16 |
Products named: VRAYLAR, Ozempic, Wegovy, PENMENVY, REPATHA, Cologuard Collection Kit, The Cologuard Plus Collection Kit, AIRSUPRA.
Industry payments across NC — which companies pay providers there.
